000 01215 a2200349 4500
005 20250515230748.0
264 0 _c20101122
008 201011s 0 0 eng d
022 _a1759-5010
024 7 _a10.1038/nrcardio.2010.84
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWareham, Nicholas J
245 0 0 _aDiabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
_h[electronic resource]
260 _bNature reviews. Cardiology
_cJul 2010
300 _a367-8 p.
_bdigital
500 _aPublication Type: News
650 0 4 _aBiomarkers
_xblood
650 0 4 _aBlood Glucose
_xmetabolism
650 0 4 _aCardiovascular Diseases
_xblood
650 0 4 _aDiabetes Complications
_xblood
650 0 4 _aDiabetes Mellitus, Type 2
_xblood
650 0 4 _aGlucose Tolerance Test
650 0 4 _aGlycated Hemoglobin
_xmetabolism
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xtherapeutic use
650 0 4 _aPredictive Value of Tests
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
700 1 _aPfister, Roman
773 0 _tNature reviews. Cardiology
_gvol. 7
_gno. 7
_gp. 367-8
856 4 0 _uhttps://doi.org/10.1038/nrcardio.2010.84
_zAvailable from publisher's website
999 _c19925258
_d19925258